Third Circuit reaffirms denial of Niaspan buyers’ class cert

A group of end-purchasers of cholesterol medication Niaspan cannot obtain class certification in a lawsuit against drugmakers Abbvie and Teva Pharmaceuticals, an appellate court has confirmed.